Clinical Trials Directory

Trials / Completed

CompletedNCT03807635

Simulated Clinical Use Testing on Safety Lancets (Test A)

Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test A)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
HTL-Strefa S.A. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A simulated clinical use testing on the HTL-Strefa's safety lancets

Detailed description

This study aims to evaluate the safety of the use of the safety lancets: ergoLance and Acti-Lance in the prevention of NSI and to evaluate the user's opinion with regards to the handling characteristics of the medical devices. The simulated use clinical study will involve healthcare professionals (HCPs) who routinely use safety lancets to collect blood samples and lay persons.

Conditions

Interventions

TypeNameDescription
DEVICEergoLance safety lancetThe ergoLance contact activated safety lancets type 450 are sterile, single-use safety lancets designed for the sampling of capillary blood from the fingertip of patients.
DEVICEActi-Lance safety lancetThe Acti-Lance safety lancet type 610 is a sterile, single use device used to carry out skin punctures for the purpose of collecting capillary blood samples.

Timeline

Start date
2018-11-30
Primary completion
2018-12-13
Completion
2018-12-13
First posted
2019-01-17
Last updated
2019-01-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03807635. Inclusion in this directory is not an endorsement.